Claritin-d and Enbrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin-d and Enbrel. Common interactions include gingival pain among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people who take Claritin-d and Enbrel have. It is created by eHealthMe based on reports of 39 people who take Claritin-d and Enbrel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

39 people who take Claritin-d and Enbrel together, and have interactions are studied.


What is Claritin-d?

Claritin-d has active ingredients of loratadine; pseudoephedrine sulfate. It is often used in allergies. eHealthMe is studying from 6,542 Claritin-d users for its effectiveness, alternative drugs and more.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 613,208 Enbrel users for its effectiveness, alternative drugs and more.

Number of Claritin-d and Enbrel reports submitted per year:

Claritin-d and Enbrel drug interactions.

Common Claritin-D and Enbrel drug interactions by gender *:

female:

  1. Gingival pain
  2. Haemorrhoids
  3. Head injury
  4. Hepatomegaly
  5. Hiatus hernia
  6. Hospitalisation
  7. Humerus fracture
  8. Hypertension
  9. Fatigue
  10. Injection site erythema

male:

  1. Bronchitis
  2. Drug ineffective
  3. Thyroid cancer
  4. Upper respiratory tract infection
  5. Weight increased
  6. Headache
  7. Hepatocellular carcinoma
  8. Infection
  9. Nasal congestion
  10. Oropharyngeal pain

Common Claritin-D and Enbrel drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hypersensitivity
  2. Injection site erythema
  3. Injection site rash
  4. Rash
  5. Urticaria

30-39:

  1. Injection site erythema

40-49:

  1. Drug ineffective
  2. Dyspepsia
  3. Dysphagia
  4. Dyspnoea
  5. Ecchymosis
  6. Enterocele
  7. Epicondylitis
  8. Exostosis
  9. Facial pain
  10. Fall

50-59:

  1. Fatigue
  2. Dizziness
  3. Ear disorder
  4. Headache
  5. Injection site erythema
  6. Sleep disorder
  7. Swelling face
  8. Arthritis infective
  9. Bronchopneumonia
  10. Dehydration

60+:

  1. Arthralgia
  2. Injection site pain
  3. Influenza
  4. Oropharyngeal pain
  5. Pyrexia
  6. Sinus congestion
  7. Activities of daily living impaired
  8. Anxiety
  9. Cyst
  10. Decreased activity

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 7 people, 17.95%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 10.26%
  3. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin-d and Enbrel?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Claritin-d and Enbrel interactions:

Browse all drug interactions of Claritin-d and Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Claritin-d interactions:

Browse all interactions between Claritin-d and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Enbrel interactions:

Browse all interactions between Enbrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine; pseudoephedrine sulfate and etanercept (the active ingredients of Claritin-d and Enbrel, respectively), and Claritin-d and Enbrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: